Summary by Futu AI
Akeso Biopharma (Cayman) Limited (the “Company”) will hold a Board of Directors meeting on Wednesday, August 28, 2024 to consider and approve the interim performance report for the six months ending June 30, 2024 and its publication. The meeting will be chaired by Dr. Xia Yu, Chairman and Executive Director, and attended by other Executive Directors, Dr. Li Baiyong, Dr. Wang Zhongmin, Dr. Zhang Peng, non-executive director Mr. Xie Ronggang, and independent non-executive directors Dr. Zeng Junwen, Dr. Xu Yan and Mr. Tan Bo. The notice of the meeting was issued by Akeso Biopharma on August 16, 2024.